Healthcare, MedTech & Digital Health Stocks in 2026: Which Companies Are Flashing Strong Buy Signals Despite Market Volatility?

Healthcare, MedTech & Digital Health Stocks in 2026: Which Companies Are Flashing Strong Buy Signals Despite Market Volatility?

Healthcare, medical technology, biotech, and digital health stocks are seeing sharply mixed momentum in 2026. While several major healthcare giants and diagnostics companies remain trapped in confirmed downtrends, a smaller group of health insurers, digital health platforms, genomics firms, and specialty healthcare providers are still flashing strong buy signals despite ongoing market volatility. Recent technical screening data highlights companies like UnitedHealth Group, Oscar Health, Guardant Health, and Glaukos among the strongest momentum names in the healthcare sector right now.

At the same time, several medical device makers, diagnostics firms, biotech companies, and healthcare technology stocks continue facing bearish technical setups, weak momentum, and severe downside pressure. Investors are increasingly favoring selective healthcare companies showing strong volume accumulation, improving technical momentum, and breakout confirmation signals rather than broad exposure across the sector.

Best Performing Healthcare & MedTech Stocks in 2026

Top Healthcare Stocks Showing Strong Buy Signals

These healthcare companies are currently outperforming much of the broader medical and biotech sector due to stronger technical structures and rising institutional interest.

Why Health Insurance Stocks Are Gaining Momentum

UnitedHealth Group (UNH)

UnitedHealth Group currently holds one of the strongest technical setups in the healthcare sector. Recent screening data shows:

• RSI above 76
• Bullish MACD signal
• Strong trend continuation
• Positive three-month returns
• Strong institutional volume activity

The stock currently carries a “Strong Buy” technical classification with high-conviction breakout confirmation signals.

Oscar Health (OSCR)

Oscar Health has emerged as one of the strongest digital healthcare momentum plays in 2026. Technical indicators show:

• RSI above 80
• Strong bullish momentum
• High ADX trend strength
• Positive volume accumulation
• Strong breakout continuation

However, analysts also warn that the stock is entering overbought territory, which could increase short-term volatility.

Digital Health & Telemedicine Stocks Showing Strength

American Well (AMWL)

American Well is showing improving technical momentum despite weakness across much of the telemedicine sector. Current indicators highlight:

• Strong bullish MACD structure
• Positive three-month returns
• Rising trend strength
• Bullish crossover signals

The stock currently carries a “Strong Buy” technical classification.

Teladoc Health (TDOC)

Teladoc Health is also showing improving momentum compared to previous quarters, although analysts remain cautious due to weaker long-term trend structure and volatile price action.

Medical Technology Stocks Showing Relative Strength

Glaukos (GKOS)

Glaukos is currently one of the strongest MedTech breakout candidates in 2026. Technical data shows:

• RSI near 70
• Bullish trend continuation
• Positive volume confirmation
• Strong relative strength
• Rising institutional participation

The stock currently ranks among the highest-rated healthcare momentum setups in the screening dataset.

Guardant Health (GH)

Guardant Health is also attracting investor attention due to improving momentum and bullish breakout signals tied to precision diagnostics and oncology testing demand.

Healthcare Stocks Facing Heavy Downtrend Pressure

Several major healthcare, biotech, and diagnostics companies remain under severe technical pressure.

Strong Sell Healthcare Stocks

These stocks continue showing bearish MACD signals, oversold stochastic readings, weak relative strength, and confirmed death cross formations.

Featured Snippet: Which Healthcare Stocks Are Strong Buys in 2026?

Top healthcare and MedTech stocks showing strong buy signals include:

1. UnitedHealth Group (UNH)
2. Oscar Health (OSCR)
3. Glaukos (GKOS)
4. Guardant Health (GH)
5. National HealthCare Corp (NHC)
6. Penumbra (PNTG)

These companies currently show strong technical momentum, bullish breakout confirmation, rising volume trends, and positive institutional activity based on recent market screening data.

AI Overview: What Investors Should Watch Next

Investors tracking healthcare and biotech stocks in 2026 should monitor:

• RSI breakout confirmation
• Institutional volume accumulation
• Digital health adoption trends
• Precision medicine growth
• Medical AI expansion
• Health insurance sector momentum

The healthcare sector is becoming increasingly selective, with institutional capital rotating toward companies showing stronger momentum, scalable digital platforms, and more resilient earnings trends.

Why Healthcare Stocks Are Becoming More Selective

Healthcare was once considered one of the market’s safest defensive sectors, but 2026 is proving that not all healthcare stocks are moving together. Investors are rewarding companies with strong revenue growth, improving momentum, digital expansion, and breakout technical structures while avoiding weaker diagnostics, biotech, and medical device names trapped in prolonged downtrends.

Companies tied to digital health, insurance technology, precision medicine, and specialty healthcare services are currently showing far stronger momentum than many traditional healthcare giants.

The healthcare sector in 2026 is showing clear divergence between momentum leaders and struggling legacy names. Stocks tied to health insurance, digital healthcare, precision diagnostics, and specialized medical technologies currently appear significantly stronger than many traditional healthcare and biotech companies facing bearish technical setups.

For investors, the key theme remains selective strength. Companies showing rising institutional accumulation, bullish momentum, and confirmed breakout structures continue leading the strongest buy lists despite broader market uncertainty.